High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM

Summary

This pilot phase I trial aims to investigate the efficacy and safety of high- and low-dose radiotherapy combined with programmed cell death-1 (PD-1) inhibitors in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) that have failed second-line immunotherapy or above.

Timeline

Start

2023-09-20

Primary completion

2024-09-30

Completion

2025-12-31

Drugs

Indications